None listed
Conditions
Brief summary
Our previous research indicates vapocoolant is effective in significantly decreasing the pain of intravenous cannulation. This new study will compare vapocoolant with subcutaneous lignocaine, another common means of reducing the pain of cannulation.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
Emergency department patients, aged 18 years or more, requiring intravenous cannulation
Exclusion criteria
Refusal to provide consent Inability to provide informed consent (Non-English speaking, altered mental state, significant illness, urgent need for IV cannulation) Moderate to severe discomfort or pain Diseases of the skin associated with cold intolerance (eg: Raynaud’s) Known allergy to spray contents or lignocaine Peripheral neuropathy Parenteral analgesia in the previous 4 hours Use of other local anaesthetics